NASDAQ · LYCA

Lycia Therapeutics short interest

$27.18+2.95%

Close Nov 2, 2026 · split-adjusted

Shares short—

Change—

% of float—

Days to cover—Short volume 38.4% (10d)

No short interest has been reported for Lycia Therapeutics.

Reading these numbers

Short interest is the number of shares sold short and not yet repurchased, reported by FINRA twice a month with a delay of about two weeks. As a share of float it shows how crowded the bet against Lycia Therapeutics is; days to cover estimates how long buying those shares back would take at average volume. Compare it with the short squeeze monitor or learn more in our short interest guide.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology